Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab′)(2) in an in vivo mouse model of alloimmune thrombocytopenia

Documenti analoghi

• Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti–HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia
  di: Bakchoul, Tamam, et al.
  Pubblicazione: (2013)
• Anti-endothelial αvβ3 antibodies are a major cause of intracranial bleeding in fetal-neonatal alloimmune thrombocytopenia
  di: Santoso, Sentot, et al.
  Pubblicazione: (2016)
• Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers
  di: Ghevaert, Cedric, et al.
  Pubblicazione: (2013)
• LOW FREQUENCY HUMAN PLATELET ANTIGENS (HPA) AS TRIGGERS FOR NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NAIT)
  di: Peterson, Julie A., et al.
  Pubblicazione: (2013)
• Drug-associated thrombocytopenia
  di: Bakchoul, Tamam, et al.
  Pubblicazione: (2018)